Ovid Therapeutics Inc. (24) | Collaboration Agreements (2)
- Collaboration and License Agreement, by and between the Company and Angelini Pharma Rare Diseases AG, dated July 9, 2020 (Filed With SEC on March 15, 2021)
- Collaboration and License Agreement, by and between the Company and Angelini Pharma Rare Diseases AG, dated July 9, 2020 (Filed With SEC on November 13, 2020)
